ALNY News and Press, Alnylam Pharmaceuticals Inc. From 02/16/24

A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 66.7% to $3.76 on volume of 298,289,429 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 70.5% to $0.1091 on volume of 172,174,410 shares Sientra Inc. (SIEN) rose 89.9% to $0.342 on volume of ...

A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 62.5% to $3.665 on volume of 269,509,234 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 64.1% to $0.105 on volume of 159,463,786 shares Sientra Inc. (SIEN) rose 119.4% to $0.395 on volume of...

2024-02-15 13:16:06 ET Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2023 Earnings Conference Call February 15, 2024 08:30 ET Company Participants Christine Lindenboom - Senior Vice President, Investor Relations and Corporate Communications Yvonne Greenstreet - Chief Execu...

2024-02-15 12:39:02 ET Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) were sinking 9.5% lower as of 11:27 a.m. ET on Thursday after falling as much as 12.6% earlier in the day. The sell-off came after the drugmaker announced its fourth-quarter and full-year 2023 results. Alnyl...

2024-02-15 09:12:07 ET More on Alnylam Pharmaceuticals Alnylam's Huge Opportunity Alnylam Pharmaceuticals: R&D Day Reveals Ambitious Plans Alnylam Pharmaceuticals Q4 2023 Earnings Preview Investors growing more bullish on SMID cap biotech stocks S...

2024-02-15 08:04:42 ET More on Alnylam Pharmaceuticals Alnylam's Huge Opportunity Alnylam Pharmaceuticals: R&D Day Reveals Ambitious Plans Alnylam Pharmaceuticals Q4 2023 Earnings Preview Investors growing more bullish on SMID cap biotech stocks S...

− Achieved Fourth Quarter and Full Year 2023 Global Net Product Revenues of $346 Million and $1,241 Million, Respectively, Representing 39% Annual Growth Compared to 2022 – − Company Announces Updated Statistical Analysis Plan and Timing for HELIOS-B Phase 3 Study of ...

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...

2024-02-14 10:52:49 ET More on Alnylam Pharmaceuticals Alnylam's Huge Opportunity Alnylam Pharmaceuticals: R&D Day Reveals Ambitious Plans Investors growing more bullish on SMID cap biotech stocks Regeneron eyes Wegovy combo to improve quality of weight l...

2024-02-05 14:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting January 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ...